Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are...

Descripción completa

Detalles Bibliográficos
Autores principales: Heymans, Stephane, Cooper, Leslie T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656440/
https://www.ncbi.nlm.nih.gov/pubmed/34887571
http://dx.doi.org/10.1038/s41569-021-00662-w
_version_ 1784612281789710336
author Heymans, Stephane
Cooper, Leslie T.
author_facet Heymans, Stephane
Cooper, Leslie T.
author_sort Heymans, Stephane
collection PubMed
description The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.
format Online
Article
Text
id pubmed-8656440
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86564402021-12-09 Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms Heymans, Stephane Cooper, Leslie T. Nat Rev Cardiol Comment The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults. Nature Publishing Group UK 2021-12-09 2022 /pmc/articles/PMC8656440/ /pubmed/34887571 http://dx.doi.org/10.1038/s41569-021-00662-w Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Heymans, Stephane
Cooper, Leslie T.
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title_full Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title_fullStr Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title_full_unstemmed Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title_short Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
title_sort myocarditis after covid-19 mrna vaccination: clinical observations and potential mechanisms
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656440/
https://www.ncbi.nlm.nih.gov/pubmed/34887571
http://dx.doi.org/10.1038/s41569-021-00662-w
work_keys_str_mv AT heymansstephane myocarditisaftercovid19mrnavaccinationclinicalobservationsandpotentialmechanisms
AT cooperlesliet myocarditisaftercovid19mrnavaccinationclinicalobservationsandpotentialmechanisms

Ejemplares similares